| Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan MW Garbowski, JP Carpenter, G Smith, M Roughton, MH Alam, T He, ... Journal of cardiovascular magnetic resonance 16 (1), 40, 2014 | 199 | 2014 |
| Atherosclerosis is aggravated by iron overload and ameliorated by dietary and pharmacological iron restriction F Vinchi, G Porto, A Simmelbauer, S Altamura, ST Passos, M Garbowski, ... European heart journal 41 (28), 2681-2695, 2020 | 189 | 2020 |
| The pathophysiology of transfusional iron overload JB Porter, M Garbowski Hematology/oncology clinics 28 (4), 683-701, 2014 | 184 | 2014 |
| Consequences and management of iron overload in sickle cell disease J Porter, M Garbowski Hematology 2013, the American Society of Hematology Education Program Book …, 2013 | 160 | 2013 |
| Eltrombopag: a powerful chelator of cellular or extracellular iron (III) alone or combined with a second chelator E Vlachodimitropoulou, YL Chen, M Garbowski, P Koonyosying, B Psaila, ... Blood, The Journal of the American Society of Hematology 130 (17), 1923-1933, 2017 | 110 | 2017 |
| Practical guide to quantification of hepatic iron with MRI B Henninger, J Alustiza, M Garbowski, Y Gandon European radiology 30, 383-393, 2020 | 107 | 2020 |
| Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding study MD Cappellini, J Porter, R Origa, GL Forni, E Voskaridou, F Galactéros, ... haematologica 104 (3), 477, 2019 | 79 | 2019 |
| Mechanisms of plasma non‐transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients JB Porter, PB Walter, LD Neumayr, P Evans, S Bansal, M Garbowski, ... British journal of haematology 167 (5), 692-696, 2014 | 66 | 2014 |
| Synergistic intracellular iron chelation combinations: mechanisms and conditions for optimizing iron mobilization E Vlachodimitropoulou Koumoutsea, M Garbowski, J Porter British journal of haematology 170 (6), 874-883, 2015 | 36 | 2015 |
| Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial AT Taher, MD Cappellini, A Kattamis, E Voskaridou, S Perrotta, AG Piga, ... The Lancet Haematology 9 (10), e733-e744, 2022 | 33 | 2022 |
| Intravenous iron preparations transiently generate non-transferrin-bound iron from two proposed pathways MW Garbowski, S Bansal, JB Porter, C Mori, S Burckhardt, RC Hider Haematologica 106 (11), 2885, 2021 | 33 | 2021 |
| Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin MW Garbowski, P Evans, E Vlachodimitropoulou, R Hider, JB Porter haematologica 102 (10), 1640, 2017 | 24 | 2017 |
| A phase 2a, open-label, dose-finding study to determine the safety and tolerability of sotatercept (ACE-011) in adults with beta (β)-thalassemia: interim results MD Cappellini, J Porter, R Origa, GL Forni, A Laadem, F Galacteros, ... Blood 122 (21), 3448, 2013 | 24 | 2013 |
| Right ventricular volumes and function in thalassemia major patients in the absence of myocardial iron overload JP Carpenter, F Alpendurada, M Deac, A Maceira, M Garbowski, P Kirk, ... Journal of Cardiovascular Magnetic Resonance 12, 1-8, 2010 | 22 | 2010 |
| A decade follow-up of a thalassemia major (TM) cohort monitored by cardiac magnetic resonance imaging (CMR): significant reduction in patients with cardiac iron and in total … AS Thomas, M Garbowski, AL Ang, FT Shah, JM Walker, JC Moon, ... Blood 116 (21), 1011, 2010 | 20 | 2010 |
| Clinical and methodological factors affecting non-transferrin-bound iron values using a novel fluorescent bead assay MW Garbowski, Y Ma, S Fucharoen, S Srichairatanakool, R Hider, ... Translational Research 177, 19-30. e5, 2016 | 19 | 2016 |
| Impact of compliance, ferritin and LIC on long-term trends in myocardial T2* with deferasirox M Garbowski, P Eleftheriou, D Pennell, M Tanner, JB Porter Blood 112 (11), 116, 2008 | 19 | 2008 |
| Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development J Porter, A Taher, V Viprakasit, A Kattamis, TD Coates, M Garbowski, ... Expert Review of Hematology 14 (7), 633-644, 2021 | 18 | 2021 |
| Calibration of Improved T2* Method for the Estimation of Liver Iron Concentration in Transfusional Iron Overload. MW Garbowski, JP Carpenter, G Smith, DJ Pennell, JB Porter Blood 114 (22), 2004, 2009 | 17 | 2009 |
| Interaction of transfusion and iron chelation in thalassemias JB Porter, MW Garbowski Hematology/Oncology Clinics 32 (2), 247-259, 2018 | 15 | 2018 |
gian luca forniMedico, ForAnemia Foundation在 galliera.it 的电子邮件经过验证
